{"protocolSection":{"identificationModule":{"nctId":"NCT01817816","orgStudyIdInfo":{"id":"CCH-061203"},"organization":{"fullName":"Changhua Christian Hospital","class":"OTHER"},"briefTitle":"Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients"},"statusModule":{"statusVerifiedDate":"2015-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-01"},"primaryCompletionDateStruct":{"date":"2015-04","type":"ACTUAL"},"completionDateStruct":{"date":"2015-06","type":"ACTUAL"},"studyFirstSubmitDate":"2013-03-21","studyFirstSubmitQcDate":"2013-03-21","studyFirstPostDateStruct":{"date":"2013-03-25","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-11-03","lastUpdatePostDateStruct":{"date":"2015-11-05","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Ta-Sen Wei,MD","investigatorTitle":"Director, Physical Medical and Rehabilitation, Principal Investigator, Clinical Professor","investigatorAffiliation":"Changhua Christian Hospital"},"leadSponsor":{"name":"Changhua Christian Hospital","class":"OTHER"}},"descriptionModule":{"briefSummary":"Spasticity, muscle weakness, abnormal gait pattern are co-morbidities commonly seen in stroke patients. They cause disabled condition of patients in activities of daily life and functional performance, and also accidental falls and subsequent fractures.\n\nThis study is to evaluate and compare the effects of different phase injection of Botulinum Toxin Type-A at affected limbs on muscle rheological changes, muscle activity, muscle tone, functional performance, gait pattern and energy consumption in stroke patients."},"conditionsModule":{"conditions":["Stroke","Spasticity"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":80,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Botox_A","type":"EXPERIMENTAL","description":"receiving Botulinum Toxin Type-A (Botox-A, Allergan) at both affected lower extremity (aLE) and upper extremity (aUE)","interventionNames":["Procedure: Botox_A"]},{"label":"placebo_A","type":"PLACEBO_COMPARATOR","description":"receiving placebo injection at both aLE \\& aUE ; receiving Botox-A at both aLE \\& aUE at 6-month.","interventionNames":["Procedure: Botox_A"]},{"label":"Botox_B","type":"EXPERIMENTAL","description":"receiving Botox-A injection at aLE and placebo injection (sterile normal saline) at aUE.","interventionNames":["Procedure: Botox_B"]},{"label":"placebo_B","type":"PLACEBO_COMPARATOR","description":"receiving placebo injection at both aLE \\& aUE ; receiving Botox-A only at aLE at 6-month.","interventionNames":["Procedure: Botox_B"]}],"interventions":[{"type":"PROCEDURE","name":"Botox_A","armGroupLabels":["Botox_A","placebo_A"]},{"type":"PROCEDURE","name":"Botox_B","armGroupLabels":["Botox_B","placebo_B"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in the muscle tone in upper and lower extremity","description":"use modified Ashworth Scale to access elbow, wrist, ankle joint muscle tone 0: normal\n\n1. slight hypertonus, at the end-range 1+: mild hypertonus, catch when limb is moved (\\<1/2)\n2. moderate hypertonus,, limbs moves easily (\\>1/2)\n3. passive movement difficult\n4. rigid","timeFrame":"4 weeks after injection"}],"secondaryOutcomes":[{"measure":"Change in the gait pattern as walking","timeFrame":"4 weeks after intervention"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* first-ever stroke, with spasticity within 3-months (MAS=2\\~3)\n* independent walking 10 meters (with assistive devices)\n\nExclusion Criteria:\n\n* recurrent stroke, cognition impaired\n* lower limb fracture\n* received anti-spasticity injection in the past","healthyVolunteers":false,"sex":"ALL","minimumAge":"45 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Changhua Christian Hospital","city":"Taiwan","state":"Changhua","zip":"500","country":"Taiwan"}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M11775","name":"Muscle Spasticity","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC05","name":"Musculoskeletal Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000019274","term":"Botulinum Toxins, Type A"},{"id":"C000542869","term":"abobotulinumtoxinA"}],"ancestors":[{"id":"D000009465","term":"Neuromuscular Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000065087","term":"Acetylcholine Release Inhibitors"},{"id":"D000049990","term":"Membrane Transport Modulators"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000018678","term":"Cholinergic Agents"},{"id":"D000018377","term":"Neurotransmitter Agents"}],"browseLeaves":[{"id":"M4873","name":"Botulinum Toxins","relevance":"LOW"},{"id":"M250157","name":"abobotulinumtoxinA","asFound":"Cross-","relevance":"HIGH"},{"id":"M20947","name":"Botulinum Toxins, Type A","asFound":"Cross-","relevance":"HIGH"},{"id":"M3163","name":"Acetylcholine","relevance":"LOW"},{"id":"M20448","name":"Cholinergic Agents","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"}]}},"hasResults":false}